Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.

There are 1,995 beds in University Hospitals Leuven, department of Neurology.

During the past decade, University Hospitals Leuven, department of Neurology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals Leuven, department of Neurology" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Universitaire Ziekenhuizen KU Leuven" with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "GlaxoSmithKline" with 2 trials sponsored and "Newron Sweden AB" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals Leuven, department of Neurology" #1 collaborator was "Astellas Pharma US, Inc." with 2 trials as a collaborator, "ICON Clinical Research" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "Byteflies" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals Leuven, department of Neurology" are "Amyotrophic Lateral Sclerosis" (4 trials), "Epilepsy" (3 trials), "Ulcerative Colitis" (2 trials), "Acute Ischemic Stroke" (1 trials) and "Cerebrovascular Accident" (1 trials). Many other conditions were trialed in "University Hospitals Leuven, department of Neurology" in a lesser frequency.

Most popular intervention types in "University Hospitals Leuven, department of Neurology" are "Drug" (13 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "sNN0029" (2 trials), "99m-Technetium Ethyl Cysteinate Dimer" (1 trials), "Etrolizumab" (1 trials) and "Etrozulimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals Leuven, department of Neurology" are 15 trials for "All" genders.

Currently, there are NaN active trials in "University Hospitals Leuven, department of Neurology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University Hospitals Leuven, department of Neurology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals Leuven, department of Neurology, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".